Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer - Rarity of co-occurrence of mutations in APC, K-ras, and p53 genes

Virchows Archiv

Volumn 445, Issue 5, 2004, Pages 465-471

  Chiang, Jy Ming ^a   Chou, Yah Huei Wu ^a   Ma, Shih Chieh ^a   Chen, Jim Ray ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Age; Carcinogenesis; Colorectal cancer; Metastases

Indexed keywords

ADULT; AGED; APC GENE; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CARCINOGENESIS; COLON POLYPOSIS; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MUTATIONAL ANALYSIS; ONCOGENE K RAS; PATHOPHYSIOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN P53 GENE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADENOMATOUS POLYPOSIS COLI; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENES, APC; GENES, P53; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MUTATION;

EID: 9944227795     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-1116-z     Document Type: Article

References (41)

1. Al-Mulla F, Going JJ, Sowden ET, Winter A, Pickford IR, Birnie GD (1998) Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. J Pathol 185:130-138
2. Astler VB, Coller FA (1954) The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139:846-848
3. Baisse B, Bouzourene H, Saraga E, Bosman FT, Benhattar J (2001) Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma. Int J Cancer 93:346-352
4. Balducci L, Beghe C (2001) Cancer and age in the USA. Crit Rev Oncol Hematol 37:137-145
5. Bazan V, Migliavacca M, Zanna I, Tubiolo C, Grassi N, Latteri MA, La Farina M, Albanese I, Dardanoni G, Salerno S, Tomasino RM, Labianca R, Gebbia N, Russo A (2002) Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Ann Oncol 13:1438-1446
6. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava SA (1998) National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257
7. Breivik J, Meling GI, Spurkland A, Rognum TO, Gaudernack G (1994) K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. Br J Cancer 69:367-371
8. Chiang JM, Chou-Wu YH, Wang JY (2000) Synchronous colorectal carcinoma and adenoma may arise from independent neoplastic colonal expansion. JS CRS ROC 11:1-7
9. Chiang JM, Chou YH, Chen TC, Ng KF, Lin JL (2002) Nuclear beta-catenin expression is closely related to ulcerative growth of colorectal carcinoma. Br J Cancer 86:1124-1129
10. Chiang JM, Chen MC, Changchien CR, Chen JS, Tang R, Wang JY, Yeh CY, Fan CW, Tsai WS (2003) Favorable influence of age on clinicopathological features of sporadic colorectal cancer. Dis Colon Rectum 46:904-910
11. Cottu PH, Muzeau F, Estreicher A, Flejou JF, Iggo R, Thomas G, Hamelin R (1996) Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines. Oncogene 13:2727-2730
12. De Filippo C, Luceri C, Caderni G, Pacini M, Messerini L, Biggeri A, Mini E, Tonelli F, Cianchi F, Dolara P (2002) Mutations of the APC gene in human sporadic colorectal cancer Scand J Gastroenterol 9:1048-1053
13. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767
14. Freedman AN, Michalek AM, Marshall JR, Mettlin CJ, Petrelli NJ, Black JD, Zhang ZF, Satchidanand S, Asirwatham JE (1996) Familial and nutritional risk factors for p53 overexpression in colorectal cancer. Cancer Epidemiol Biomarkers Prev 5:285-291
15. Goh HS, Chan CS, Khine K, Smith DR (1994) P53 and behavior of colorectal cancer. Lancet 344:233-234
16. Hermsen M, Postma C, Baak J, Weiss M, Rapallo A, Sciutto A, Roemen G, Arends JW, Williams R, Giaretti W, De Goeij A, Meijer G (2002) Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 123:1109-1119
17. Jervoise H, Andreyev N, Norman AR, Cunningham D, Oates JR, Clarke PA (1998) Kirsten ras mutations in patients with colorectal cancer: the multicenter 'RASCAL' study. J Natl Cancer Inst 90:675-684
18. Kastrinakis WV, Ramchurren N, Rieger KM, Hess DT, Loda M, Steele G, Summerhayes IC (1995) Increased incidence of p53 mutations is associated with hepatic of metastasis in colorectal neoplastic progression. Oncogene 11:647-652
19. Laurent-Puig P, Olschwang S, Delattre O, Validire P, Melot T, Mosseri V, Salmon RJ, Thomas G (1991) Association of Ki-ras mutation with differentiation and tumor-formation pathways in colorectal carcinoma. Int J Cancer 49:220-223
20. Leslie A, Pratt NR, Gillespie K, Sales M, Kernohan NM, Smith G, Wolf R, Carey FA, Steele RJC (2003) Mutations of APC, K-ras, and p53 are associated with specific chromosomal aberrations in colorectal adenocarcinomas. Cancer Res 63:4656-4661
21. Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, Marshall CJ (1991) Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 51:3497-3502
22. Liang JT, Cheng YM, Chang KJ, Chien CT, Hsu HC (1999) Reappraisal of K-ras and p53 gene mutations in the recurrence of Dukes'B2 rectal cancer after curative resection. Hepatogastrointerology 46:830-837
23. Liang JT, Huang KC, Cheng AL, Jeng YM, Wu MS, Wang SM (2003) Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. Br J Surg 90:205-214
24. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85
25. Liu B, Farrington SM, Petersen GM, Hamilton SR, Parsons R, Papadopoulos N, Fujiwara T, Jen J, Kinzler KW, Wyllie AH (1995) Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med 1:348-352
26. Makino H, Ushijima T, Kakiuchi H, Onda M, Ito N, Sugimura T, Nagao M (1994) Absence of p53 mutations in rat colon tumors induced by 2-amino-6- methyldipyrido [1, 2-a:3′, 2′-d] imidazole, 2-amino-3-methylimidazo [4, 5-f] quinoline, or 2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine. Jpn J Cancer Res 85:510-514
27. Miyki M, Iijima T, Yasuno M, Kita Y, Hishima T, Kuroki T, Mori T (2002) High incidence of protein-truncating mutations of the p53 gene in liver metastases of colorectal carcinoma. Oncogene 21:6689-6693
28. Nakamura Y (1993) The role of the adenomatous polyposis coli (APC) gene in human cancer. Adv Cancer Res 62:65-87
29. Obrador A, Moreno V, Bautista D, Cabeza E, Canet R (1998) Colorectal cancer, diet, and p53 Gastroenterology, 114[Suppl 4]:G2705, part 2
30. Pauly M, Schmitz M, Kayser I, Tureci O, Tureci O, Lagoda P, Seitz G, Dicato M (1997) Ki-ras oncogene and p53 tumor suppressor gene mutations in colorectal carcinomas from the European Saar-Luxembourg region are less frequent than predicted by the classic adenoma-carcinoma sequence model. Eur J Cancer 33:2265-2272
31. Pollack IF, Finkelstein SD, Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Finlay JL, Sposto R (2001) Children's Cancer Group. Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort. Cancer Res 61:7404-7407
32. Prosser J, Condie A, Wright M, Horn JM, Fantes JA, Wyllie AH, Dunlop MG (1994) APC mutation analysis by chemical cleavage of mismatch and a protein truncation assay in familial adenomatous polyposis. Br J Cancer 70:841-846
33. Samowitz WS, Holden JA, Curtin K, Edwards SL, Walker AR, Lin HA, Robertson MA, Nichols MF, Gruenthal KM, Lynch BJ, Leppert MF, Slattery ML (2001) Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol 158:1517-1524
34. Samowitz WS, Curtin K, Ma KN, Edwards S, Schaffer D, Leppert MF, Slattery ML (2002) Prognostic significance of p53 mutations in colon cancer at the population level. Int J Cancer 99:597-602
35. Sedivy R, Wolf B, Kalipciyan M, Steger GG, Karver-Hanusch J, Moder RM (2000) Genetic analysis of multiple synchronous lesions of the colon adenoma-carcinoma sequence, Br J Cancer 82:1276-1282
36. Shen L, Kondo Y, Hamilton SR, Rashid A, Issa JP (2003) P14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53. Gastroenterology 124:626-633
37. Smith G, Carey FA, Beattie J, Wilkie MJ, Lightfoot TJ, Coxhead J, Garner RC, Steele RJ, Wolf CR (2002) Mutations in APC, Kirsten-ras, and p53 - alternative genetic pathways to colorectal cancer. PNAS 99:9433-9438
38. Suh JH, Lim SD, Kim JC, Hong SH, Kang GH (2002) Comparison of clinicopathologic characteristics and genetic alterations between microsatellite instability-positive and microsatellite instability-negative sporadic colorectal carcinomas in patients younger than 40 years old. Dis Colon Rectum 45:219-228
39. van der Luijt R, Khan PM, Vasen H, van Leeuwen C, Tops C, Roest P, den Dunnen J, Fodde R (1994) Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test. Genomics 20:1-4
40. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532
41. Zauber NP, Sabbath-Solitare M, Marotta SP, Zauber AG, Bishop DT (2001) Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient. J Pathol 93:303-309